These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23624135)

  • 1. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol day curves in Addison's disease in patients on hydrocortisone replacement.
    Ross IL; Levitt NS; Van der Walt JS; Schatz DA; Johannsson G; Haarburger DH; Pillay TS
    Horm Metab Res; 2013 Jan; 45(1):62-8. PubMed ID: 22893258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous subcutaneous hydrocortisone infusion therapy in Addison's disease: a randomized, placebo-controlled clinical trial.
    Gagliardi L; Nenke MA; Thynne TR; von der Borch J; Rankin WA; Henley DE; Sorbello J; Inder WJ; Torpy DJ
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4149-57. PubMed ID: 25127090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
    J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased physical activity, reduced QoL and presence of debilitating fatigue in patients with Addison's disease.
    van der Valk ES; Smans LC; Hofstetter H; Stubbe JH; de Vries M; Backx FJ; Hermus AR; Zelissen PM
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):354-60. PubMed ID: 26953557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
    BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addison's disease.
    Giordano R; Guaraldi F; Marinazzo E; Fumarola F; Rampino A; Berardelli R; Karamouzis I; Lucchiari M; Manetta T; Mengozzi G; Arvat E; Ghigo E
    Endocrine; 2016 Feb; 51(2):360-8. PubMed ID: 26184416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable sensitivity to the glucocorticoid activity of cortisol in patients with primary adrenal insufficiency: assessment with ACTH profiles.
    Ekman B; Blomgren J; Andersson PO; Carlsson M; Arnqvist HJ
    Horm Metab Res; 2010 Dec; 42(13):961-6. PubMed ID: 20925018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in patients with Addison's disease: effects of different cortisol replacement modes.
    Riedel M; Wiese A; Schürmeyer TH; Brabant G
    Exp Clin Endocrinol; 1993; 101(2):106-11. PubMed ID: 8405139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
    Restituto P; Galofré JC; Gil MJ; Mugueta C; Santos S; Monreal JI; Varo N
    Clin Biochem; 2008 Jun; 41(9):688-92. PubMed ID: 18280810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grapefruit juice and licorice increase cortisol availability in patients with Addison's disease.
    Methlie P; Husebye EE; Hustad S; Lien EA; Løvås K
    Eur J Endocrinol; 2011 Nov; 165(5):761-9. PubMed ID: 21896619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid replacement therapy: are patients over treated and does it matter?
    Peacey SR; Guo CY; Robinson AM; Price A; Giles MA; Eastell R; Weetman AP
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):255-61. PubMed ID: 9156031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.